Effect of frequent or extended hemodialysis on cardiovascular parameters: a meta-analysis

Paweena Susantitaphong1, Ioannis Koulouridis, Ethan M Balk

  • 1Department of Medicine, Division of Nephrology, Kidney and Dialysis Research Laboratory, St. Elizabeth's Medical Center, Boston, MA 02135, USA.

Insights

More frequent or extended hemodialysis (HD) significantly reduces left ventricular mass index (LVMI) and improves cardiac function in patients with chronic kidney failure. This may offer long-term cardiovascular benefits, though more trials are needed.

Area of Science:

  • Nephrology and Cardiology
  • Cardiovascular Health in Chronic Kidney Disease

Background:

  • Increased left ventricular (LV) mass is a significant risk factor for cardiovascular mortality in patients with chronic kidney failure.
  • More frequent or extended hemodialysis (HD) is hypothesized to beneficially impact LV mass.

Purpose of the Study:

  • To evaluate the effect of frequent or extended hemodialysis on cardiac morphology and function.
  • To assess changes in blood pressure parameters with intensified HD regimens.

Main Methods:

  • A meta-analysis of single-arm cohort studies and trials was conducted.
  • Searched MEDLINE, Cochrane Central Register, and ClinicalTrials.gov for studies on frequent/extended HD.
  • Included studies examining cardiac morphology, function, and blood pressure; excluded hemofiltration, hemodiafiltration, and peritoneal dialysis.

Main Results:

  • Frequent or extended HD significantly reduced LV mass index (LVMI) by -31.2 g/m(2) (P < 0.001) in meta-analysis.
  • LV ejection fraction improved by 6.7% (P = 0.01), with other cardiac parameters showing similar improvements.
  • Significant decreases were observed in systolic, diastolic, and mean blood pressure, along with reduced antihypertensive medication use.

Conclusions:

  • Conversion to frequent or extended HD is linked to improved cardiac morphology and function, including LVMI and LV ejection fraction.
  • Observed improvements in cardiac parameters and blood pressure may confer long-term cardiovascular benefits.
  • Further trials with long-term clinical outcomes are necessary to confirm these benefits.
Abstract

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...